FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,872 letters match. Newest first.

  1. Jiangsu Kerbio Medical Technology Group Co.

    FDA cites Jiangsu Kerbio Medical Technology Group for serious GLP violations in medical device safety testing.

    High risk
  2. CCIC Huatongwei International Inspection Co., Ltd.

    FDA warns CCIC Huatongwei after inspection found copied data and missing records in medical device safety tests.

    High risk
  3. Meds For Vets, LLC

    Meds For Vets compounded unapproved animal drugs from bulk substances and failed manufacturing quality rules, including sterility controls.

    High risk
  4. Anhui Hanbon Daily Chemical Co., Ltd.

    FDA warns Anhui Hanbon Daily Chemical over CGMP failures in OTC drugs, including use of an incorrect excipient and untested ingredients.

    High risk
  5. Boothwyn Pharmacy LLC

    FDA warns Boothwyn Pharmacy over unapproved compounded animal drugs and falsified endotoxin records.

    High risk
  6. Chaohu Daxin Foodstuffs Co., Ltd.

    FDA warns Chaohu Daxin Foodstuffs that its ready-to-eat cooked crawfish from China is adulterated due to an inadequate seafood HACCP plan and poor sanitation.

    High risk
  7. ABBE Laboratories, Inc.

    FDA warns ABBE Laboratories over manufacturing failures for over-the-counter topical drugs, including ingredient testing.

    High risk
  8. K & Care Organics

    FDA warns K & Care Organics over unapproved over-the-counter (OTC) foam sunscreen drugs sold in the U.S. without required authorization.

    High risk
  9. Confer With

    FDA told London-based Confer With that its Vivant True Tone skin-lightening serum is an unapproved drug sold without FDA approval.

    High risk
  10. Spectra Therapy, LLC

    FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.

    High risk
  11. Gussyup LLC dba Private Label Grooming

    FDA found Gussyup LLC, a Henderson, Nevada OTC drug maker, lacking quality oversight and ingredient identity testing; company stopped drug production.

    High risk
  12. TKO Distribution, LLC

    FDA warned TKO Distribution that its Delta-8 THC gummy products are adulterated because Delta-8 THC is an unsafe food additive.

    High risk
  13. Orchid Grocery

    FDA says Orchid Grocery did not have required foreign supplier verification for imported sesame seeds, supplement and fish masala.

    Medium
  14. Oasis Medical, Inc.

    FDA cites Oasis Medical for current good manufacturing practice violations in sterile ophthalmic drugs, including particulate contamination and unresolved sterility failures.

    High risk
  15. Mectronic Medicale S.R.L.

    FDA warns Mectronic Medicale over quality system failures and uncleared marketing of therapeutic RF/laser devices.

    High risk
  16. Shiva Analyticals Private Limited

    FDA warned Shiva Analyticals, an Indian contract drug testing lab, that inadequate OOS investigations and data integrity failures adulterated tested drugs.

    High risk
  17. Onkos Surgical, Inc.

    FDA warns Onkos Surgical over ELEOS implant system cleaning, corrective-action, risk, sampling, and removal-reporting failures.

    High risk
  18. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  19. www.mysteroidsmarket.com

    FDA warns Israel-based website mysteroidsmarket.com for selling unapproved and misbranded stimulants and benzodiazepines to U.S. consumers.

    High risk
  20. www.portmeds.com

    FDA warned www.portmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants online without prescriptions.

    High risk
  21. www.plakini-pharma.com

    FDA warned Malaysia-based website plakini-pharma.com for selling unapproved, misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  22. Macsen Drugs

    FDA cites Macsen Drugs for releasing fire-exposed APIs and inadequate stability data at India plant.

    High risk
  23. Leltek Inc.

    FDA warns Leltek over quality-system failures for LU700 and LK128 ultrasound systems, including corrective actions, complaints, records, and adverse-event reporting.

    Medium
  24. Glenmark Pharmaceuticals Limited

    FDA warns Glenmark over unresolved dissolution failures and inadequate investigations at its Pithampur, India drug plant.

    High risk
  25. Medical Chemical Corporation

    FDA warned Medical Chemical Corp over manufacturing violations, unapproved Tincture Green Soap, and improper drug listing.

    High risk
  26. O3UV, LLC

    FDA warns O3UV that its Champion and EBOO ozone/UV blood devices are unapproved, misbranded, and made without required quality controls.

    High risk
  27. Nature’s Fusions LLC

    FDA cited Nature's Fusions for over-the-counter hand sanitizer manufacturing with inadequate stability, component and finished-product testing, and water controls.

    High risk
  28. IndulgeRx Brands, Inc

    FDA says IndulgeRx's FightBack nut butters are unapproved new drugs because website and label claims target cancer and disease.

    Medium
  29. WHOOP, Inc.

    FDA warns WHOOP it markets Blood Pressure Insights without device clearance or approval.

    High risk
  30. Scope Health Inc

    FDA says Scope Health sold unapproved OTC eye drugs online and misbranded several products.

    High risk
  31. Revitalize Energy, Inc.

    FDA warned Revitalize Energy that its Revitalize Energizing Eye Drops are an unapproved new drug and misbranded.

    High risk
  32. Daewoo Pharmaceutical Co., Ltd.

    FDA warns Daewoo Pharmaceutical over CGMP (manufacturing quality rules) failures at Busan plant; company suspended production.

    High risk
  33. Mark J. Savant, M.D

    FDA warns clinical investigator Mark J. Savant, M.D., over protocol dosing and eligibility failures and missing informed consent in a drug trial.

    High risk
  34. 7Tabz Retail, LLC

    FDA says 7Tabz Retail sells unapproved 7-OH drug products online with drug-like claims.

    High risk
  35. Royal Diamond Imports, Inc.

    FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.

    High risk
  36. Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ

    FDA says Thang Botanicals' 7OHMZ kratom shot, tablets, and gummies contain unsafe 7-OH and are adulterated.

    High risk
  37. My Smoke Wholesale

    My Smoke Wholesale's 777 Jackpot Alkaloids tablets are adulterated dietary supplements because 7-OH lacks adequate safety information.

    High risk
  38. A.D. Berries @ More LLC

    FDA says Texas importer A.D. Berries @ More had no foreign supplier verification program for imported avocados and celery.

    Medium
  39. Libby Laboratories, Inc.

    FDA warned Libby Laboratories of Berkeley, California, that its drug manufacturing violated CGMP, including releasing a hospital antiseptic without microbial testing.

    High risk
  40. Xtreme Tools International, Inc.

    FDA warned Xtreme Tools International after an inspection found manufacturing-rule failures for OTC topical drugs, including missing ingredient and batch testing.

    High risk
  41. Lystn LLC dba Answers Pet Food

    FDA warned Answers Pet Food that its raw pet food contained Salmonella and Listeria and was made under insanitary conditions.

    High risk
  42. Dynamic Blending Specialists, Inc.

    FDA cited Dynamic Blending Specialists for manufacturing failures in OTC drugs and an unapproved, misbranded oral antiseptic.

    High risk
  43. Exela Pharma Sciences, LLC

    Exela Pharma Sciences failed CGMP (current good manufacturing practice) for sterile injectable drugs, including invalidated sterility-media tests and inaccurate microbiology records.

    High risk
  44. InVia Fertility Specialists, PLLC

    FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.

    High risk
  45. www.buynetmeds.com

    FDA warned www.buynetmeds.com for selling unapproved, misbranded tapentadol and semaglutide drugs, including injectables, to U.S. consumers online.

    High risk
  46. Healwell Homeo Private Limited

    FDA warns Healwell Homeo over pest-infested drug storage and manufacturing violations.

    High risk
  47. Staska Pharmaceuticals, Inc.

    FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.

    High risk
  48. Pushclean Technology Plastik Sanayi Ve Ticaret Ltd. Sirketi

    FDA warns Turkish OTC drug wipe maker Pushclean over missing finished-product and component testing.

    High risk
  49. www.soma4ever.com

    FDA warned soma4ever.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers online.

    High risk
  50. Sterling Distributors

    FDA warned Florida drug wholesaler Sterling Distributors for shipping prescription drugs without licenses and ignoring a counterfeit report.

    High risk